Subscribe To
Humacyte (huma) completes enrollment in hav technology study
Humacyte (HUMA) surges as it completes patient enrollment in a late-stage clinical study on the human acellula...
April 12, 2023, 2:25 pm
Aligos therapeutics to present data from chronic hepatitis b and hepatocellular carcinoma programs at the european association for the study of the liver (easl) congress 2023
SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company f...
April 11, 2023, 6:50 pm
Perimeter medical imaging ai finishes 2022 on strong footing after doubling the commercial installed base of perimeter s-series oct
Perimeter Medical Imaging AI (TSX-V:PINK, OTC:PYNKF) finished the 2022 financial year on a strong footing, with cash and equivalents of nearly US$28.4...
April 11, 2023, 4:41 pm
Cult food science announces mou with jellatech to create collagen-enhanced pet foods
CULT Food Science Corp (CSE:CULT, OTCQB:CULTF) has announced a partnership with JellaTech, a company producing collagen through cel...
April 11, 2023, 8:03 am
Intra-cellular (itci) up 20.5% since last earnings report: can it continue?
Intra-Cellular (ITCI) reported earnings 30 days ago. What's next for the stock?...
March 31, 2023, 1:04 pm
Intra-cellular (itci) depression drug meets study goal, stock up
Intra-Cellular Therapeutics (ITCI) announces positive top-line data from its phase III study evaluating...
March 29, 2023, 1:46 pm
Cell tower reits: 5g's killer app
Cell Tower REITs have been one of the weakest-performing property sectors since early 2022, an uncharacteristic stretch of poor performance following ...
March 29, 2023, 10:00 am
Intra-cellular (itci) surges 16.4%: is this an indication of further gains?
Intra-Cellular (ITCI) saw its shares surge in the last session with trading volume being higher than av...
March 29, 2023, 6:54 am
Why intra-cellular therapies climbed tuesday
Caplyta, the company's lead drug, was responsible for most of the company's revenue in 2022. The potential addition of major depressive disorder to th...
March 28, 2023, 12:27 pm
Intra-cellular's big depression drug market just got bigger — and shares catapulted
Intra-Cellular said Tuesday its depression treatment succeeded in a key study, and ITCI stock broke def...
March 28, 2023, 10:04 am
Intra-cellular's stock jumps on new data for depression drug
Shares of Intra-Cellular Therapies Inc. ITCI, +2.46% jumped about 15% in premarket trading on Tuesday a...
March 28, 2023, 8:16 am
Brainstorm to announce fourth quarter and fiscal year 2022 financial results and provide a corporate update
NEW YORK , March 21, 2023 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cel...
March 21, 2023, 8:18 am
Celularity, inc. (celu) is a trending stock: facts to know before betting on it
Celularity, Inc. (CELU) has received quite a bit of attention from Zacks.com users lately. Therefore, i...
March 17, 2023, 10:44 am
Spacex reportedly to test satellite-to-cellular service this year
The company will reportedly test on T-Mobile's network....
March 13, 2023, 7:01 pm
Starlink and t-mobile's sat-to-cell service will start testing this year
SpaceX and T-Mobile will begin testing a new service to bring satellite connectivity to cell phones this year, a SpaceX executive said. The news, firs...
March 13, 2023, 6:35 pm
Brazil’s lula says judiciary should force businesses to pay equal salaries
SAO PAULO (Reuters) – The Brazilian judiciary should work on compelling businesses to pay equal wages for men and women in the same roles, Brazil’...
March 8, 2023, 11:21 pm
Why is ast spacemobile (asts) stock up 12% today?
Amid a soft start to the week on Wall Street, global cellular broadband network provider AST SpaceMobil...
March 6, 2023, 3:38 pm
Fate therapeutics to present at upcoming march investor conferences
SAN DIEGO, March 03, 2023 (GLOBE NEWSWIRE) — Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage...
March 3, 2023, 9:01 pm
Fate therapeutics to present at upcoming march investor conferences
SAN DIEGO, March 03, 2023 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (the “Company” or “Fate Therapeutics”) (NASDAQ: FATE), a clinical-stage ...
March 3, 2023, 4:01 pm
Brazil’s economy stalled last year; lula blames high borrowing costs
By Marcela Ayres BRASILIA (Reuters) – Brazil’s economy shrank in the fourth quarter, affected by industry weakness and consolidating a slowdown th...
March 3, 2023, 1:58 am